Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPF Technologies is a private U.S. life science tools company that develops separation, purification, filtration, and sample-preparation technologies for the biopharmaceutical industry. Its offerings include the Chromassette chromatography cassette platform, VacuCon vacuum concentrators, ultra-thin channel filtration, and single-pass tangential filtration technologies. The company appears to operate primarily as a platform and device developer rather than a therapeutics developer, supporting bioprocessing, bioanalytics, and downstream manufacturing workflows. SPF Technologies has also pursued a licensing-oriented business model, including an exclusive rights and joint development agreement with JSR Life Sciences for the Chromassette platform. Overall, the company is best characterized as an active private bioprocessing tools and technology company serving biopharma manufacturing and research customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPF Technologies.